原发性中枢神经系统淋巴瘤切除术的安全性:单中心回顾性分析
该研究回顾性分析了2000至2015年在哥伦比亚大学医学中心治疗的原发性中枢神经系统淋巴瘤(PCNSL)患者,采用Glioma Outcomes Project系统评估活检或切除术后的并发症率。切除术后总体并发症率为17.2%,活检后为28.2%。心脏风险(p=0.047,OR 1.72 [1.01, 2.95])和合并症诊断(p=0.004,OR 3.05 [1.42, 6.57])可预测并发症。作者认为对于经过选择的患者,PCNSL手术切除是安全的,并发症率与其他颅内肿瘤相当,但切除是否有临床获益尚不能得出结论。
要点
- 切除术后总体并发症率为17.2%,活检后为28.2%。
- 心脏风险(p=0.047,OR 1.72 [1.01, 2.95])和合并症诊断(p=0.004,OR 3.05 [1.42, 6.57])预测并发症。
- 作者认为对经过选择的患者,PCNSL切除是安全的,但临床获益尚不能结论。
核心结论
- 对于经过选择的患者,PCNSL手术切除是安全的,并发症率与其他颅内肿瘤相当,但切除是否有临床获益尚不能得出结论。
研究设计与样本
- 单中心回顾性分析,纳入2000至2015年在哥伦比亚大学医学中心治疗的所有PCNSL患者,使用Glioma Outcomes Project系统评估活检或切除术后的并发症率,并分析并发症预测因素和切除选择因素。
主要发现
- 切除术后总体并发症率为17.2%,活检后为28.2%。
- 多变量回归显示心脏风险(p=0.047,OR 1.72 [1.01, 2.95])和合并症诊断(p=0.004,OR 3.05 [1.42, 6.57])预测并发症。
- 接受切除术的患者KPS评分更好(中位70 vs 80,p=0.0068,∆ 10 [0.0, 10.00]),较少有多发病灶(46.5% vs 27.6%,p=0.030,OR 1.42 [1.05, 1.92])或深部病灶(70.4% vs 39.7%,p=0.001,OR 1.83 [1.26, 2.65])。
- 多变量回归显示年龄(p=0.048,每增加10岁OR 0.75 [0.56, 1.00])和深部病灶(p=0.003,OR 0.29 [0.13, 0.65])影响切除选择。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Surgical resection is not the standard of care for primary central nervous system lymphoma (PCNSL), as historical studies have demonstrated unfavorable complication rates and limited benefits. Some recent studies suggest that resection may provide a therapeutic benefit, yet the safety of these procedures has not been systematically investigated in the setting of modern neurosurgery. We examined the safety of surgical resection for PCNSL. We retrospectively analyzed all patients with PCNSL treated at Columbia University Medical Center between 2000 and 2015 to assess complications rates following biopsy or resection using the Glioma Outcomes Project system. We identified predictors of complications and selection for resection. Well-validated scales were used to quantify patients' baseline clinical characteristics, including functional status, comorbid disease burden, and cardiac risk. The overall complication rate was 17.2% after resection, and 28.2% after biopsy. Cardiac risk (p = 0.047, OR 1.72 [1.01, 2.95]), and comorbid diagnoses (p = 0.004, OR 3.05 [1.42, 6.57]) predicted complications on multivariable regression. Patients who underwent resection had better KPS scores (median 70 v. 80, p = 0.0068, ∆ 10 [0.0, 10.00]), and were less likely to have multiple (46.5% v. 27.6%, p = 0.030, OR 1.42 [1.05, 1.92]) or deep lesions (70.4% v. 39.7%, p = 0.001, OR 1.83 [1.26, 2.65]). Age (p = 0.048, OR 0.75 per 10-year increase [0.56, 1.00]) and deep lesions (p = 0.003, OR 0.29 [0.13, 0.65]) influenced selection for resection on multivariable regression. Surgical resection of PCNSL is safe for select patients, with complication rates comparable to rates for other intracranial neoplasms. Whether there is a clinical benefit to resection cannot be concluded.
引用
- Cloney MB, Sonabend AM, Yun J, et al. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis. J Neurooncol. 2017. PMID: 28116650. doi:10.1007/s11060-016-2358-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。